ResearcherWuhan Union HospitalActive in the last 2 years
Jungang Zhang
Matched on ORCID iD 0000-0003-1642-7554; OpenAlex author ID A5103158636. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2013: 5 papers · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 8
- The acidic microenvironment promotes pancreatic cancer progression via the lncRNA-LOC100507424/E2F1/FOXM1 axis. Last author DOI 10.1186/s12885-025-14073-4↗
- Bioinformatic analysis of FOXN3 expression and prognostic value in pancreatic cancer. Last author DOI 10.3389/fonc.2022.1008100↗
- Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy-induced stress. Co-author DOI 10.1111/cas.12364↗
- Nicotinamide prohibits proliferation and enhances chemosensitivity of pancreatic cancer cells through deregulating SIRT1 and Ras/Akt pathways. Co-author DOI 10.1016/j.pan.2013.01.001↗
- miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKα1. First author DOI 10.1158/1535-7163.mct-12-0534-t↗
- miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. Co-author DOI 10.1158/1535-7163.mct-13-0296↗
- Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer. Co-author DOI 10.1245/s10434-012-2364-9↗
- MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3. First author DOI 10.1371/journal.pone.0073803↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Deyang Mu · 1 shared paper, 2025 · strength 0.28
- Gang Zhao · 6 shared papers, 2013–2014 · strength 0.21
- Paper Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy-induce… DOI 10.1111/cas.12364↗
- Paper Nicotinamide prohibits proliferation and enhances chemosensitivity of pancreatic cancer cells through deregulating SIRT… DOI 10.1016/j.pan.2013.01.001↗
- Paper Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancr… DOI 10.1245/s10434-012-2364-9↗
- Chunyou Wang · 6 shared papers, 2013–2014 · strength 0.21
- Paper Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy-induce… DOI 10.1111/cas.12364↗
- Paper Nicotinamide prohibits proliferation and enhances chemosensitivity of pancreatic cancer cells through deregulating SIRT… DOI 10.1016/j.pan.2013.01.001↗
- Paper Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancr… DOI 10.1245/s10434-012-2364-9↗
- Shichang Deng · 5 shared papers, 2013 · strength 0.17
- Paper Nicotinamide prohibits proliferation and enhances chemosensitivity of pancreatic cancer cells through deregulating SIRT… DOI 10.1016/j.pan.2013.01.001↗
- Paper Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancr… DOI 10.1245/s10434-012-2364-9↗
- Paper miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKα1. DOI 10.1158/1535-7163.mct-12-0534-t↗
- Qi Qin · 5 shared papers, 2013 · strength 0.17
- Paper Nicotinamide prohibits proliferation and enhances chemosensitivity of pancreatic cancer cells through deregulating SIRT… DOI 10.1016/j.pan.2013.01.001↗
- Paper Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancr… DOI 10.1245/s10434-012-2364-9↗
- Paper miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKα1. DOI 10.1158/1535-7163.mct-12-0534-t↗
- Dongsheng Huang · 1 shared paper, 2022 · strength 0.15
- Yu Wei · 1 shared paper, 2022 · strength 0.15
- Xiang Li · 3 shared papers, 2013 · strength 0.10
- Paper miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKα1. DOI 10.1158/1535-7163.mct-12-0534-t↗
- Paper miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. DOI 10.1158/1535-7163.mct-13-0296↗
- Paper MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STA… DOI 10.1371/journal.pone.0073803↗
- Shuai Zhu · 2 shared papers, 2013 · strength 0.06
- Paper miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4. DOI 10.1158/1535-7163.mct-13-0296↗
- Paper MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STA… DOI 10.1371/journal.pone.0073803↗
- Defei Hong · 1 shared paper, 2014 · strength 0.04
- Jian Cheng · 1 shared paper, 2014 · strength 0.04
- Xiao‐dong Sun · 1 shared paper, 2014 · strength 0.04
- Yi Niu · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.